Toggle navigation
EN
PL
Company
About us
Experience
Our Clients
Recruitment
Internship program 2023
Privacy policy
Requests for quotation
Data protection
Research and development
Designing and planning of R&D process
Project organisation and management
Project assessment and its commercialisation
Regulatory Due Diligence Analysis
Audit of manufacturing sites/laboratories
Nitrosamine - risk analysis
Transfer of Analytical Methods
Support and brokerage in product portfolio optimization
Audits
Remote GxP Audits
Preclinical and clinical development
Planning, organisation and monitoring of trials
Pharmacovigilance
Pharmacovigilance System
Risk Management Plan (RMP)
Local literature monitoring
Preparing Addendum to Clinical Overview
Case reports handling
Scientific service
Pharmacovigilance in Clinical Trials
Regulatory Affairs Services
Regulatory outsourcing
Pre-authorisation
Handling of the registration process
Post-authorisation
Importation services
Import and supply chain management
News
Contact
www.sciencepharma.com
News
EU Law
HMA: Procedural Advice on Repeat-Use.
HMA: Procedural Advice on Repeat-Use.
12.08.2011
This document describes the procedure to be adopted for “Repeat Use”.
The source of the news:
http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/procedural_guidance/Application_for_MA/CMDh_008_2009_Rev7_Clean.pdf
SciencePharma
